Research Manager 2026/Cp/168
hace 9 horas
Valladolid
Job Title: ORALREGENERIX – In?Clinic Oral Tissue Regeneration Using Handheld Bioprinting Technology Location: CICA CENTRO INTERDISCIPLINAR DE QUÍMICA E BIOLOGÍA, University of A Coruña Schedule: Monday to Friday, 9:30 – 13:30 and 16:00 – 19:00 The Advanced Biofabrication for Tissue Engineering research group, led by Daniel Nieto at the University of A Coruña, seeks a Chief Executive Officer (CEO) with proven experience in strategic management, fundraising, and scaling of technology and biomedical startups to work within the framework of the ORALREGENERIX project. Previous experience in deeptech, biotech, medtech, or technology spin‑offs will be highly valued. • Development and execution of the business plan., • Securing public and private funding (venture capital, business angels, grants, EIC, CDTI, etc.)., • Managing investor relationships and preparing investment rounds., • Developing strategic alliances and commercial agreements., • Coordinating regulatory activities and market access strategy., • Overseeing organizational growth and business structuring., • Representing the company before investors, partners, and public bodies., • Supporting intellectual property and commercialization strategy., • Proven experience in managing and leading technology or biomedical startups., • Experience in investment acquisition and fundraising., • Experience in negotiating with investors and closing funding rounds., • Experience in business development and corporate strategy., • Knowledge of the startup ecosystem, venture capital, and technology transfer., • Experience in regulated environments (medical devices, biotech, digital health, or similar)., • Knowledge of regulations and quality standards applicable to medical devices (asset)., • Previous experience as CEO or member of management team of startups., • Experience with university spin‑offs., • Experience with CE/FDA regulatory processes., • Experience implementing quality systems (ISO ... or others)., • Previous participation in exits, M&A, or business scaling processes., • Established network of contacts with investors and strategic partners. #J-18808-Ljbffr